home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9605a.zip
/
M9650052.TXT
< prev
next >
Wrap
Text File
|
1996-03-09
|
2KB
|
35 lines
Document 0052
DOCN M9650052
TI [Vaginal and intrauterine contraception]
DT 9605
AU Serfaty D; Centre de regulation des naissances Hopital, Saint-Louis,;
Paris.
SO Rev Prat. 1995 Dec 1;45(19):2407-15. Unique Identifier : AIDSLINE
MED/96148041
AB Vaginal contraception (condom, diaphragm and spermicide in pessary,
tablet, jelly, cream, or sponge form) have been little used in France
and generally in Europe since the advent of modern contraception with
the pill and the intrauterine contraceptive device. The former methods,
when properly used, are nevertheless both effective and useful, at least
as interim measures. In addition, the protection they afford against
sexually transmitted diseases and, for the condom, against HIV, is not
negligible. Finally, the barrier methods of contraception such as the
diaphragm and the condom afford significant protection against cancer of
the cervix. The intrauterine contraceptive device (IUCD), used in France
by 14% of women between 15 and 49 years of age and by 90 million women
throughout the world for whom it is the main reversible means of
contraception, have a mechanism of action that is still not fully
understood. Most IUCD now used are made of copper. There are also
diffusion IUCD based on progesterone or a synthetic progestational
hormone which are useful in case of anaemia, menorrhagia or
dysmenorrhea.
DE Administration, Intravaginal Contraceptive Agents/*ADMINISTRATION &
DOSAGE/CONTRAINDICATIONS Contraceptive
Devices/*CLASSIFICATION/CONTRAINDICATIONS English Abstract Female
Human *Intrauterine Devices Male JOURNAL ARTICLE REVIEW REVIEW,
MULTICASE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).